Furthermore, the expression of interferon-beta (IFN-β) (a marker of the Type I IFN signalling pathway) decreased significantly in the tumours of the DDX58-KO group compared to the WT group following Dox treatment (Figures 7G, J). Here, IFNB1 is linked to neoplasm.